On the occasion of the 10th anniversary of the Innovative Medicines Initiative (IMI), Luxinnovation and its partners will be holding an international conference and networking event. The conference will take place tomorrow, December 14th, at the premises of the Laboratoire National de Santé (LNS) in Dudelange, Luxembourg.
Organised by Luxinnovation in partnership with the Luxembourg Centre for Systems Biomedicine, IBBL, the LNS and the Luxembourg Institute of Health (LIH), the event aims to promote the dissemination of IMI project outcomes and foster networking between private companies and public health research institutes. It will therefore attract participants from the entire healthcare value chain, including hospitals, academia, research infrastructures and biotech and pharmaceutical companies seeking new opportunities for collaboration within the framework of IMI and beyond.
The conference “Medical data valorisation and sustainability” will focus on how the long-term use of data generated through current and future IMI projects (e.g. multi-omics, imaging, real world data, etc.) can be made secure, sustainable and of the best benefit to the patient. IBBL will contribute to the discussions by presenting the work done in the context of two IMI projects in which it is involved, namely LITMUS (Liver Investigation: Testing Marker Utility in Steatohepatitis) and CANCER-ID (Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood). The former aims to develop and validate highly accurate blood tests and imaging techniques that will allow doctors and researchers to rapidly and easily diagnose the severity of the disease in individual patients and monitor changes in their livers. The latter aims to develop new, less invasive ways of capturing cancerous cells and cancer genetic material from blood samples and analysing them for clues as to what treatment is needed and how well drugs are working.
The conference will alternate project presentations with several matchmaking sessions, and will be followed by a networking cocktail during which participants will be able to exchange best practices and meet representatives from the pharmaceutical industry, biotech companies, academia and research infrastructures to forge new partnerships in medical research.
The event will take place from 8.30 am until 6 pm, followed by the networking reception until 8 pm. The full programme and detailed information can be found on the dedicated event page.
The is the world’s biggest public-private partnership in the field of life sciences between the European Union and the European pharmaceutical industry. With a budget of € 3.3 billion over 2014-2020, IMI aims to fund research projects that advance the development of, and patient access to, personalised and innovative medicines, especially in areas with unmet medical needs.